ArticleCureus2025
Screening for Modifiable Risk Factors of Noncommunicable Diseases in Urban Young Adults, Indore, 2023-2024.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionNoncommunicable diseases (NCDs) lead to huge mortality in the population under 70 years of age at a global level. A national program called the National Programme for Prevention and Control of NCDs (NPNCD), targeting mainly individuals over 30 years of age, has been launched in India. Nearly 200 million Indians are young adults (ages 18-30 years). The levels of modifiable risk factors in this young adult population, as well as the prevalence of NCDs, remain undocumented. We conducted this study to identify the extent of modifiable risk factors among individuals aged 18-30 years in Indore.
methodsWe conducted a cross-sectional study in Indore between 2023 and 2024. We planned to screen 10,000 young adults, based on a pre-calculated sample size table, by organizing camps in educational institutes. The paper-based tool collected data on sociodemography, behavioral risk factors, family history, dietary recall, and anthropometry. The samples were tested in a National Accreditation Board for Testing and Calibration Laboratories (NABL)-accredited lab in Indore. The biochemical tests conducted were fasting blood glucose, total serum cholesterol, serum creatinine, and serum glutamate pyruvate transaminase (SGPT). We performed descriptive epidemiology and analyzed the data for correlation using the chi-square test.
resultsThe median (range) age of screened individuals was 20 (18-30) years. The median (IQR) BMI was 20 (18-22.4). Approximately 46% (4607) of individuals had elevated systolic blood pressure. Among females, 44% (2483) had elevated systolic blood pressure, whereas it was 50% (2199) among males. Abnormal blood glucose levels were observed in 4.0% (398), abnormal cholesterol levels in 5.3% (528), abnormal creatinine levels in 4.9% (491), and abnormal SGPT levels in 8.1% (809). The p-value for the correlation between tobacco consumption and elevated blood pressure, serum creatinine, serum cholesterol, and SGPT was <.05.
conclusionApproximately 25% of the screened individuals were classified as underweight, while fewer than 25% were overweight. About 50% exhibit hypertension, with a higher prevalence in males. Individuals who have elevated blood pressure, serum creatinine, cholesterol, and SGPT levels exhibit an increased likelihood of tobacco consumption. We need to screen more young adults for modifiable risk factors and develop strategies to help them in mitigating these risks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.